Published in Graefes Arch Clin Exp Ophthalmol on March 15, 2005
Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol (2014) 1.02
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol (2006) 0.90
Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application. Drug Des Devel Ther (2015) 0.77
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization. Clin Ophthalmol (2017) 0.75
Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan. Taiwan J Ophthalmol (2015) 0.75
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol (2001) 7.60
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology (2001) 3.12
Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology (1984) 2.03
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Etiology of choroidal neovascularization in young patients. Ophthalmology (1996) 1.74
Pathologic myopia and choroidal neovascularization. Am J Ophthalmol (1981) 1.49
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol (2003) 0.96
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol (2004) 0.93
Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia. Retina (1998) 0.90
Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg (1987) 0.88
Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'. Eye (Lond) (2004) 0.86
Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2004) 0.83
Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes. Br J Ophthalmol (2003) 0.81
Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes. Am J Ophthalmol (2003) 0.78
Müller cells in the healthy and diseased retina. Prog Retin Eye Res (2006) 5.07
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology (2010) 3.22
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci (2009) 3.19
Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res (2009) 2.30
Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol (2013) 2.07
Peeling of the basal membrane in the human retina: ultrastructural effects. Ophthalmology (2004) 1.80
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol (2006) 1.72
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina (2015) 1.67
Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol Scand (2005) 1.64
Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochem Int (2008) 1.59
Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae. Plant J (2005) 1.57
Pathomechanisms of cystoid macular edema. Ophthalmic Res (2004) 1.52
Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci (2014) 1.46
Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci (2008) 1.42
Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol (2007) 1.42
Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol (2012) 1.38
Silicone oil-RMN3 mixture ("heavy silicone oil") as internal tamponade for complicated retinal detachment. Retina (2003) 1.36
Elaborate spatial patterning of cell-wall PME and PMEI at the pollen tube tip involves PMEI endocytosis, and reflects the distribution of esterified and de-esterified pectins. Plant J (2007) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea. Lab Invest (2003) 1.33
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci (2007) 1.32
Müller glial cells in retinal disease. Ophthalmologica (2011) 1.31
Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci (2008) 1.28
Microcystic macular degeneration from optic neuropathy. Brain (2012) 1.27
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. Ophthalmology (2012) 1.26
A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol Cell Neurosci (2004) 1.23
A role for pectin de-methylesterification in a developmentally regulated growth acceleration in dark-grown Arabidopsis hypocotyls. New Phytol (2010) 1.23
Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol (2009) 1.23
Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat. Invest Ophthalmol Vis Sci (2008) 1.21
Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci (2009) 1.20
Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17
Glial cell reactivity in a porcine model of retinal detachment. Invest Ophthalmol Vis Sci (2006) 1.15
The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model. Invest Ophthalmol Vis Sci (2009) 1.15
Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol (2002) 1.14
Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res (2004) 1.13
Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes (2006) 1.10
Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci (2012) 1.07
Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J (2010) 1.06
Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol (2009) 1.05
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated properties. Anal Chem (2012) 1.03
Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci (2011) 1.03
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients]. Klin Monbl Augenheilkd (2002) 1.03
Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells. Neurochem Res (2012) 1.01
The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther (2005) 1.01
Proprioception in total, hemi- and reverse shoulder arthroplasty in 3D motion analyses: a prospective study. Int Orthop (2008) 1.00
MMP-2 and MMP-9 secretion by rpe is stimulated by angiogenic molecules found in choroidal neovascular membranes. Retina (2006) 1.00
Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci (2002) 1.00
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
A population-based survey on tanning bed use in Germany. BMC Dermatol (2009) 0.98
Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci (2007) 0.97
Analysis of surgical intervention populations using generic surgical process models. Int J Comput Assist Radiol Surg (2010) 0.97
Angiogenesis-related factors derived from retinal glial (Müller) cells in hypoxia. Neuroreport (2004) 0.96
Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci (2007) 0.96
Ocular inflammation alters swelling and membrane characteristics of rat Müller glial cells. J Neuroimmunol (2005) 0.96
Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J Neurosci Res (2006) 0.96
Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica (2005) 0.96
P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Invest Ophthalmol Vis Sci (2003) 0.95
Effects of ischemia-reperfusion on physiological properties of Müller glial cells in the porcine retina. Invest Ophthalmol Vis Sci (2011) 0.94
Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia (2004) 0.94
Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress. J Neurosci Res (2010) 0.94
Occlusion of choroidal vessels in a patient with catastrophic antiphospholipid syndrome. Acta Ophthalmol (2010) 0.94
Purinergic signaling involved in Müller cell function in the mammalian retina. Prog Retin Eye Res (2011) 0.93
Early activation of inflammation- and immune response-related genes after experimental detachment of the porcine retina. Invest Ophthalmol Vis Sci (2008) 0.93
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol (2013) 0.92
Characterization of the basic fibroblast growth factor-evoked proliferation of the human Müller cell line, MIO-M1. Graefes Arch Clin Exp Ophthalmol (2004) 0.92
p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia (2008) 0.92
Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 0.92
PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis. Exp Cell Res (2004) 0.92
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.91
Database supported candidate search for metabolite identification. J Integr Bioinform (2011) 0.91
Glutamate-evoked alterations of glial and neuronal cell morphology in the guinea pig retina. J Neurosci (2004) 0.91
Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol Vis (2005) 0.91
Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells. Biochem Biophys Res Commun (2006) 0.91
Human retinal epithelium produces and responds to placenta growth factor. Graefes Arch Clin Exp Ophthalmol (2005) 0.90
Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (2002) 0.90
Differential regulation of Kir4.1 and Kir2.1 expression in the ischemic rat retina. Neurosci Lett (2005) 0.90
Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina. Neurosci Lett (2005) 0.90
Extracellular invertase is involved in the regulation of clubroot disease in Arabidopsis thaliana. Mol Plant Pathol (2010) 0.90
Retinal endothelial angiogenic activity: effects of hypoxia and glial (Müller) cells. Microcirculation (2004) 0.90
Vitrectomy for pre-macular hemorrhagic cyst in children and young adults. Graefes Arch Clin Exp Ophthalmol (2005) 0.89
Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol (2003) 0.89
Müller cell response to blue light injury of the rat retina. Invest Ophthalmol Vis Sci (2008) 0.89
Long-term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with ranibizumab. Ophthalmologica (2013) 0.89
Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions. Glia (2007) 0.89
Recovery from hepatic retinopathy after liver transplantation. Graefes Arch Clin Exp Ophthalmol (2003) 0.89
Regulation of pigment epithelium-derived factor production and release by retinal glial (Müller) cells under hypoxia. Invest Ophthalmol Vis Sci (2008) 0.89
External application of gametophyte-specific ZmPMEI1 induces pollen tube burst in maize. Plant Reprod (2013) 0.88
Flexible UV light guiding system for intraocular laser microsurgery. Lasers Surg Med (2007) 0.88
Glial cell-derived glutamate mediates autocrine cell volume regulation in the retina: activation by VEGF. J Neurochem (2007) 0.88
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.88
The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium. J Neuroimmunol (2005) 0.87
Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats. Eur J Pharmacol (2011) 0.87